The alliance strategy outlined by Paul Watt in the January 2017 presentation includes a dot point on multiple licensing structures: license existing FPPs for particular cargoes or targets.
BioExec outlined a very similar strategy in his post of 21 February 2016 when he suggested Phylogica could give FPPs to a number of companies to "test drive with their favourite cargo" under a MTA. BioExec said that;
"This way they could license a single [FPP] out over and over again, for various cargos, and have these efforts run parallel to their own internal work."
Is this what is now happening?
The alliance strategy outlined by Paul Watt in the January 2017...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19940 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 1008 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |